UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2380) 2380
science & technology (2250) 2250
life sciences & biomedicine (2174) 2174
niacinamide - analogs & derivatives (1875) 1875
male (1478) 1478
female (1309) 1309
middle aged (1205) 1205
oncology (1187) 1187
aged (1062) 1062
sorafenib (983) 983
antineoplastic agents - therapeutic use (958) 958
phenylurea compounds - therapeutic use (896) 896
phenylurea compounds (850) 850
phenylurea compounds - adverse effects (821) 821
antineoplastic agents - adverse effects (809) 809
adult (774) 774
treatment outcome (733) 733
liver neoplasms - drug therapy (654) 654
carcinoma, hepatocellular - drug therapy (631) 631
pyridines - adverse effects (614) 614
pyridines - therapeutic use (610) 610
niacinamide - therapeutic use (584) 584
phenylurea compounds - administration & dosage (582) 582
antineoplastic agents (537) 537
niacinamide - adverse effects (505) 505
biological and medical sciences (493) 493
protein kinase inhibitors - therapeutic use (484) 484
benzenesulfonates - adverse effects (473) 473
tumors (472) 472
medical sciences (467) 467
protein kinase inhibitors - adverse effects (464) 464
benzenesulfonates - therapeutic use (457) 457
cancer (456) 456
carcinoma, renal cell - drug therapy (452) 452
care and treatment (444) 444
aged, 80 and over (428) 428
hepatocellular carcinoma (427) 427
kidney neoplasms - drug therapy (423) 423
antimitotic agents (415) 415
animals (385) 385
pharmacology & pharmacy (378) 378
niacinamide - administration & dosage (372) 372
liver neoplasms - pathology (360) 360
disease-free survival (349) 349
phenylurea compounds - pharmacology (349) 349
antineoplastic agents - administration & dosage (334) 334
carcinoma, hepatocellular - pathology (334) 334
pyridines - administration & dosage (320) 320
antineoplastic combined chemotherapy protocols - therapeutic use (315) 315
medicine & public health (313) 313
drug therapy (310) 310
liver cancer (308) 308
retrospective studies (299) 299
hepatoma (290) 290
metastasis (279) 279
analysis (259) 259
chemotherapy (258) 258
gastroenterology & hepatology (247) 247
benzenesulfonates - administration & dosage (231) 231
research (231) 231
neoplasm staging (226) 226
antineoplastic combined chemotherapy protocols - adverse effects (223) 223
prognosis (223) 223
kidney neoplasms - pathology (220) 220
protein kinase inhibitors - administration & dosage (214) 214
pharmacology. drug treatments (212) 212
vascular endothelial growth factor (209) 209
clinical trials (208) 208
dose-response relationship, drug (203) 203
liver neoplasms - mortality (203) 203
patients (203) 203
indoles - therapeutic use (201) 201
carcinoma, hepatocellular - mortality (200) 200
kaplan-meier estimate (200) 200
disease progression (197) 197
antineoplastic agents - pharmacology (193) 193
pyrroles - therapeutic use (190) 190
neoplasms - drug therapy (188) 188
neoplasm metastasis (187) 187
indoles - adverse effects (186) 186
pyrroles - adverse effects (178) 178
cancer therapies (175) 175
hematology, oncology and palliative medicine (168) 168
carcinoma, renal cell (166) 166
time factors (166) 166
digestive system diseases (165) 165
renal cell carcinoma (165) 165
liver neoplasms - therapy (163) 163
mice (162) 162
young adult (162) 162
carcinoma, hepatocellular - therapy (160) 160
survival rate (154) 154
carcinoma, renal cell - pathology (152) 152
risk factors (151) 151
neoplasms (150) 150
hematology (145) 145
niacinamide - pharmacology (144) 144
pharmacology/toxicology (144) 144
bevacizumab (143) 143
survival analysis (143) 143
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2481) 2481
Japanese (39) 39
German (30) 30
French (27) 27
Chinese (12) 12
Spanish (7) 7
Portuguese (5) 5
Russian (4) 4
Czech (3) 3
Dutch (2) 2
Hungarian (2) 2
Italian (2) 2
Polish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3412 - 3419
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Pharmacology. Drug treatments | Tumors | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents | Index Medicus
Journal Article
Nature biotechnology, ISSN 1087-0156, 01/2010, Volume 28, Issue 1, pp. 63 - 70
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 03/2020, Volume 84, pp. 101966 - 101966
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 2, pp. 172 - 179
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 552 - 562
Journal Article